MAD2B Blunts Chronic Unpredictable Stress and Corticosterone Stimulation-Induced Depression-Like Behaviors in Mice

Xiao-Lan Wang1,2, Cheng Miao2, Yanfang Su2

  • 1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Abstract

Insights

Mitotic arrest deficient protein (MAD2B) plays a key role in depression. Increasing MAD2B in the brain protected against depression-like behaviors by regulating the miR-29b-3p/GRM4 pathway, suggesting MAD2B as a therapeutic target.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • Depression is a common and recurring psychiatric disorder linked to abnormal neural structure and activity.
  • Mitotic arrest deficient protein (MAD2B), highly expressed in neurons, may influence central nervous system synaptic plasticity.
  • The specific role of MAD2B in depression and its underlying molecular mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of MAD2B in depression.
  • To elucidate the molecular mechanisms by which MAD2B affects depression.
  • To explore MAD2B as a potential therapeutic target for depressive disorders.

Main Methods:

  • Mouse models of depression were established using chronic unpredictable stress and corticosterone (CORT) stimulation.
  • Depression-like behaviors were assessed using sucrose preference, forced swimming, and tail suspension tests.
  • MAD2B and glutamate metabotropic receptor 4 (GRM4) levels were analyzed, alongside miR-29b-3p expression, in hippocampal tissues and primary neuronal cells.

Main Results:

  • MAD2B expression was decreased in the hippocampus of mice exhibiting depression-like behaviors.
  • Overexpression of MAD2B in the hippocampus protected mice against depression-like behaviors induced by stress or CORT.
  • MAD2B overexpression reduced GRM4 expression and increased miR-29b-3p levels in neuronal cells, an effect also observed under CORT stimulation.

Conclusions:

  • Neuronal MAD2B is crucial in depression pathogenesis through the miR-29b-3p/GRM4 signaling pathway.
  • MAD2B demonstrates potential as a therapeutic target for depressive disorders.
  • Further research into the MAD2B pathway could yield novel depression treatments.

Related Concept Videos